3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Gynecologic
1
Genitourinary
1
Dermatologic
1
Conditions
Ovarian Neoplasms
1
Melanoma
1
Kidney Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
pembrolizumab
10
Filgrastim
7
Ifosfamide
4
Carboplatin
4
aldesleukin
3
Temozolomide
3
Peripheral Blood Stem Cell Transplantation
3
Drug Therapy
3
Docetaxel
3
Cyclophosphamide
3
Counseling
3
fludarabine phosphate
2
fludarabine
2
etoposide phosphate
2
cemiplimab
2
belinostat
2
atezolizumab
2
Thiotepa
2
Surveys and Questionnaires
2
Radiotherapy
2
Nivolumab
2
Methods
2
Metformin
2
Early Intervention, Educational
2
Doxorubicin
2
Bupropion
2
Blood Specimen Collection
2
Amifostine
2
3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol
2
valspodar
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Kidney Neoplasms
×
Dried Blood Spot Testing
×
Gynecologic
×
Clear all
NCT04154163
2022-02-28
ADOPT
University of Dundee
Completed
18 enrolled